MONROVIA, Calif., May 6 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, May 13, 2010 at the Pfister Hotel in Milwaukee, Wisconsin.

Barry G. Caldwell, President and CEO, and Deborah Andrews, CFO, will meet with interested investors in a series of one-on-one meetings.

The Benchmark Company First Annual Investor Conference does not provide for companies to webcast this event; however, a copy of the Company's Conference presentation will be available at the Company's website, www.staar.com, under Investor Information. Investors planning to attend the conference should contact their Benchmark representative to arrange a meeting.

About STAAR Surgical

STAAR, which has been solely dedicated to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." A lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." Over 150,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at: www.staar.com or call 626-303-7902.

SOURCE STAAR Surgical Company